Hardware Podcasts

192 - What Is a Drug/Device Combination Product? (Non-Technical, Under 5 Minutes)

Let's Combinate · 11 Jun 2025 · 4m

What this episode covers

Subhi Saadeh, host of Let's Combinate and Quality Professional, explains the definition and classification of drug-device combination products. He distinguishes between drug-led products, such as prefilled syringes where the drug provides the therapeutic effect, and device-led products like drug-eluting stents where the mechanical action is primary. Saadeh further categorizes these products by their configuration: single-entity (integrated), co-packaged, and cross-labeled.

Most relevant to

established companies

Topics

Mentioned

Products
prefilled syringe, drug-eluting stent, autoinjector, nebulizer

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

    Medical & health devicesCertification & compliance
    8 chapters

  • Global Medical Device Podcast · 42m

    #323 The Combination Products Handbook

    Susan Neadle, principal consultant and president of Combination Products Consulting Services, discusses her peer-reviewed book, The Combination Products Handbook: A Practical Guide, published by CRC Press. Neadle explains how she collaborated with FDA officials, including John Barwiener, and industry experts from companies like Johnson & Johnson, Novartis, and Pfizer to create a consolidated resource for the complex niche of combination products. The episode details the book's structure, covering regulatory strategies, CGMPs, risk management, and human factors, while highlighting the challenges of harmonizing terminology between pharmaceutical and medical device sectors. Neadle emphasizes the importance of holistic thinking and integrated development to ensure patient safety and regulatory compliance across global jurisdictions.

    Medical & health devicesCertification & compliance
    9 chapters

  • Global Medical Device Podcast · 40m

    #405: Over the Counter (OTC) vs. Prescription (RX) Medical Devices, Pt. 1

    Regulatory strategist Dr. Mike Drues of Vascular Sciences explains the regulatory distinctions between prescription (Rx) and over-the-counter (OTC) medical devices, emphasizing that OTC status depends on intended user, environment, and risk rather than just device class. He highlights label expansion strategies, citing CPAP machines and continuous glucose monitors (CGMs) as examples of devices moving from Rx to OTC, and discusses the critical importance of usability testing that reflects diverse patient populations rather than just healthcare professionals. Dr. Drues also addresses the misconception that home-use devices are automatically safe or OTC, noting that many Rx devices are used at home, and outlines the characteristics required for OTC status, including self-diagnosis, self-selection, and low potential for misuse.

    Validation & product-market fitQuality & yield
    10 chapters

  • Global Medical Device Podcast · 38m

    How to Choose the Right FDA Regulatory Pathway for your Device

    Mike Drues of Vascular Sciences joins host John Spear to explain that medical device companies have 7 major FDA regulatory pathways, including 510(k), PMA, De Novo, HDE, PDP, CDE, and EAP, rather than just the two commonly known options. Drues details how classification depends on both technology and labeling, allowing companies to 'wordsmith' claims to access different routes, such as using a Humanitarian Device Exemption (HDE) for narrow patient populations or a Custom Device Exemption (CDE) for personalized 3D-printed devices. The discussion highlights strategic combinations, such as using an Emergency Access Program (EAP) for early feasibility data before a full PMA, or pursuing anatomy-specific pathways for the same device. Drues also clarifies that programs like Breakthrough Devices Program (BDP) and Safer Technologies Program (STEP) are not standalone pathways but efficiency accelerators for standard submissions.

    Certification & compliance
    8 chapters

  • Global Medical Device Podcast · 50m

    #396: Mastering Device Descriptions: The Cornerstone of Medical Device Submissions

    Regulatory consultant Mike Drues, president of Vascular Sciences, explains why device descriptions are the most poorly written part of FDA submissions and how they determine classification, testing, and approval pathways. He advises manufacturers to write layered descriptions—simple overviews for general audiences and detailed appendices for specialists—and to test efficacy by having unfamiliar readers explain the device back to them. Drues recommends using videos to demonstrate device function during pre-submission meetings to avoid real-time failures and suggests starting with simple objects like a garden hose to refine the writing process.

    Certification & complianceIndustrial & consumer product design
    6 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.